The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The yeast RGG motif-containing RNA binding protein Scd6 and its human ortholog LSM14A regulate the translation of specific ...

Highlights of BioNTech’s oncology programs to be presented at AACR 2025: ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Just as the government can present bottlenecks to change, it can also identify and avoid them during a crisis.

A new study published in Genetics in Medicine identifies a novel disease-associated gene, GPKOW, that plays an important role ...

The most recent trading session ended with Moderna (MRNA) standing at $24.73, reflecting a -1.85% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...

A new study published in the International Journal of Molecular Sciences suggests that the cannabinoid cannabinerol (CBNR) ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That ...

Science Tokyo will introduce a new vision-driven integrated research framework across the Institute in April 2025 to create enhanced societal impact across various key areas. Driving the model forward ...

The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...